Skip to main content
Log in

Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability

  • Published:
Journal of Computer-Aided Molecular Design Aims and scope Submit manuscript

Abstract

High throughput microsomal stability assays have been widely implemented in drug discovery and many companies have accumulated experimental measurements for thousands of compounds. Such datasets have been used to develop in silico models to predict metabolic stability and guide the selection of promising candidates for synthesis. This approach has proven most effective when selecting compounds from proposed virtual libraries prior to synthesis. However, these models are not easily interpretable at the structural level, and thus provide little insight to guide traditional synthetic efforts. We have developed global classification models of rat, mouse and human liver microsomal stability using in-house data. These models were built with FCFP_6 fingerprints using a Naïve Bayesian classifier within Pipeline Pilot. The test sets were correctly classified as stable or unstable with satisfying accuracies of 78, 77 and 75% for rat, human and mouse models, respectively. The prediction confidence was assigned using the Bayesian score to assess the applicability of the models. Using the resulting models, we developed a novel data mining strategy to identify structural features associated with good and bad microsomal stability. We also used this approach to identify structural features which are good for one species but bad for another. With these findings, the structure-metabolism relationships are likely to be understood faster and earlier in drug discovery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Kola I, Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3(8):711–715

    Article  CAS  Google Scholar 

  2. Masimirembwa CM, Thompson R, Andersson TB (2001) In vitro high throughput screening of compounds for favorable metabolic properties in drug discovery. Comb Chem High Throughput Screen 4(3):245–263

    CAS  Google Scholar 

  3. Di L et al (2005) Development and application of high throughput plasma stability assay for drug discovery. Int J Pharm 297(1–2):110–119

    CAS  Google Scholar 

  4. Di L et al (2003) Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates. J Biomol Screen 8(4):453–462

    Article  CAS  Google Scholar 

  5. Sakiyama Y et al (2008) Predicting human liver microsomal stability with machine learning techniques. J Mol Graph Model 26(6):907–915

    Article  CAS  Google Scholar 

  6. Lee PH et al (2007) Development of in silico models for human liver microsomal stability. J Comput Aided Mol Des 21(12):665–673

    Article  CAS  Google Scholar 

  7. Shen M et al (2003) Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. J Med Chem 46(14):3013–3020

    Article  CAS  Google Scholar 

  8. Chang C et al (2009) The development and validation of a computational model to predict rat liver microsomal clearance. J Pharm Sci 98(8):2857–2867

    Article  CAS  Google Scholar 

  9. Fox T, Kriegl JM (2006) Machine learning techniques for in silico modeling of drug metabolism. Curr Top Med Chem 6(15):1579–1591

    Article  CAS  Google Scholar 

  10. Martignoni M, Groothuis GM, de Kanter R (2006) Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2(6):875–894

    Article  CAS  Google Scholar 

  11. Sun H (2006) An accurate and interpretable bayesian classification model for prediction of HERG liability. ChemMedChem 1(3):315–322

    Article  CAS  Google Scholar 

  12. Cruciani G et al (2005) MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J Med Chem 48(22):6970–6979

    Article  CAS  Google Scholar 

  13. Di L et al (2006) High throughput microsomal stability assay for insoluble compounds. Int J Pharm 317(1):54–60

    Article  CAS  Google Scholar 

  14. Di L et al (2008) Applications of high throughput microsomal stability assay in drug discovery. Comb Chem High Throughput Screen 11(6):469–476

    Article  CAS  Google Scholar 

  15. Carhart RE, Smith DE, Venkataraghavan R (1985) Atom pairs as molecular features in structure-activity studies: definition and applications. J Chem Inf Comput Sci 25(2):64–73

    CAS  Google Scholar 

  16. www.accelrys.com. Accessed Mar 2009

  17. Dunn G, Everitt B (1995) Clinical biostatistics: an introduction to evidence-based medicine. A Hodder Arnold Publication, London

  18. Boyer D et al (2009) Utility of MetaSite in improving metabolic stability of the neutral indomethacin amide derivative and selective cyclooxygenase-2 inhibitor 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)-N-phenethyl-aceta mide. Drug Metab Dispos 37(5):999–1008

    Article  CAS  Google Scholar 

  19. Caron G, Ermondi G, Testa B (2007) Predicting the oxidative metabolism of statins: an application of the MetaSite algorithm. Pharm Res 24(3):480–501

    Article  CAS  Google Scholar 

  20. Trunzer M, Faller B, Zimmerlin A (2009) Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation. J Med Chem 52(2):329–335

    Article  CAS  Google Scholar 

  21. Xia X et al (2004) Classification of kinase inhibitors using a Bayesian model. J Med Chem 47(18):4463–4470

    Article  CAS  Google Scholar 

  22. http://www.moldiscovery.com. Accessed Mar 2009

Download references

Acknowledgments

The authors thank Dr. Gary Walker for assistance with data retrieving. We thank Drs. Kristi Fan, Natasja Brooijmans, and Jason Cross for discussions on experimental design. Also we would like to mention our appreciation to Dr. David Diller for his help on preparing this manuscript. We thank Drs. Tarek Mansour and Will Somers for their support of this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yongbo Hu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hu, Y., Unwalla, R., Denny, R.A. et al. Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability. J Comput Aided Mol Des 24, 23–35 (2010). https://doi.org/10.1007/s10822-009-9309-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10822-009-9309-9

Keywords

Navigation